MOESM1 of ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia

Additional file 1. Whole-genome expression analyses of ALS and CTL patient blood samples. Table columns list the first author with publication year, gene expression profiling platform, PubMed identifier, GEO series accession (if available), cell types analyzed, and the number of samples used for expression profiling. Only studies of blood-derived cell types are included. Full references are listed below the table with additional relevant information (see footnotes)